Clinical Trial Update: Effect of Empagliflozin on Inflammation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating the effect of empagliflozin on inflammation in patients with coronary artery disease. The study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Hotel Dieu de France Hospital | Conditions: CAD - Coronary Artery Disease, Inflamation | Phase 4 | Status: RECRUITING